Utility of a clinical practice guideline in treatment of chylothorax in the postoperative congenital heart patient
- PMID: 23915583
- PMCID: PMC3886283
- DOI: 10.1016/j.athoracsur.2013.05.058
Utility of a clinical practice guideline in treatment of chylothorax in the postoperative congenital heart patient
Abstract
Background: Chylothorax after congenital heart surgery is a common complication with associated morbidities, but consensus treatment guidelines are lacking. Variability exists in the duration of medical treatment and timing for surgical intervention.
Methods: After institution of a clinical practice guideline for management of postoperative chylothorax at a single center, pediatric cardiothoracic intensive care unit (ICU) in June 2010, we retrospectively analyzed 2 cohorts of patients: those with chylothorax from January 2008 to May 2010 (early cohort; n=118) and from June 2010 to August 2011 (late cohort; n=45). Data collected included demographics, cardiac surgical procedure, treatments for chylothorax, bloodstream infections, hospital mortality, length of hospitalization, duration of mechanical ventilation, and device utilization.
Results: There were no demographic differences between the cohorts. No differences were found in octreotide use or surgical treatments for chylothorax. Significant differences were found in median times to chylothorax diagnosis (9 in early cohort versus 6 days in late cohort, p=0.004), ICU length of stay (18 vs 9 days, p=0.01), hospital length of stay (30 vs 23 days, p=0.005), and total durations of mechanical ventilation (11 vs 5 days, p=0.02), chest tube use (20 vs 14 days, p=0.01), central venous line use (27 vs 15 days, p=0.001), and NPO status (9.5 vs 6 days, p=0.04).
Conclusions: Institution of a clinical practice guideline for treatment of chylothorax after congenital heart surgery was associated with earlier diagnosis, reduced hospital length of stay, mechanical ventilation, and device utilization for these patients.
Keywords: 18; BSI; CPG; CVL; EC; ICU; LC; NPO; RACHS-1; Risk Adjustment for Congenital Heart Surgery; TPN; bloodstream infections; central venous line; clinical practice guideline; early cohort; intensive care unit; late cohort; nil per os; total parenteral nutrition.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Invited commentary.Ann Thorac Surg. 2013 Sep;96(3):936-7. doi: 10.1016/j.athoracsur.2013.06.026. Ann Thorac Surg. 2013. PMID: 23992691 No abstract available.
References
-
- Buttiker V, Fanconi S, Burger R. Chylothorax in children: Guidelines for diagnosis and management. Chest. 1999;116(3):682–687. - PubMed
-
- Cannizzaro V, Frey B, Bernet-Buettiker V. The role of somatostatin in the treatment of persistent chylothorax in children. Eur J Cardiothorac Surg. 2006;30(1):49–53. - PubMed
-
- Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: An evidence-based management algorithm. J Paediatr Child Health. 2008;44(12):716–721. - PubMed
-
- Allen EM, van Heeckeren DW, Spector ML, Blumer JL. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg. 1991;26(10):1169–1174. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
